SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-415250
Filing Date
2014-11-17
Accepted
2014-11-17 16:50:34
Documents
3
Period of Report
2014-11-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d821571d8k.htm 8-K 29731
2 EX-3.1 d821571dex31.htm EX-3.1 5110
3 EX-3.2 d821571dex32.htm EX-3.2 84205
  Complete submission text file 0001193125-14-415250.txt   120641
Mailing Address 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address 11080 ROSELLE STREET SAN DIEGO CA 92121 8583342100
AMBIT BIOSCIENCES CORP (Filer) CIK: 0001131543 (see all company filings)

IRS No.: 330909648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35919 | Film No.: 141228434
SIC: 2834 Pharmaceutical Preparations